Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Y-box binding protein 1 pseudogene 9 (YBX1P9) is a non-coding pseudogene corresponding to the Y-box binding protein 1 (YBX1) gene. Pseudogenes such as YBX1P9 are DNA sequences similar to known genes but are nonfunctional; they do not produce a functional protein because of mutations, deletions, or truncations. Therefore, YBX1P9 does not have direct biological roles, is not involved in signaling or regulatory pathways, does not serve as a therapeutic target, and is not directly implicated in disease or pharmacology. Information about molecular functions, disease roles, or drug interactions applies to the functional gene/protein (YBX1), not to its pseudogenes like YBX1P9. Pseudogenes may sometimes be transcribed into RNA, but there is no evidence that YBX1P9 is functional or clinically relevant as a therapeutic target. YBX1P9 is not a molecular target; it is a pseudogene with no current relevance as a drug target, biomarker, or therapeutic mechanism. Information on druggability, disease involvement, or function pertains to YBX1, not YBX1P9.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Y-box binding protein 1 pseudogene 9 (YBX1P9).